Quest Acquires PathAI to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis
Quest Diagnostics and PathAI formed a collaboration to advance the adoption of AI and digital pathology technology for cancer diagnosis.
Read MorePosted by Andy Lundin | May 1, 2024 | Digital Pathology |
Quest Diagnostics and PathAI formed a collaboration to advance the adoption of AI and digital pathology technology for cancer diagnosis.
Read MorePosted by Andy Lundin | Apr 30, 2024 | Molecular Diagnostics |
New AI-based technology may change how autism is diagnosed, using biological marker analysis for earlier and more accurate detection.
Read MorePosted by Andy Lundin | Apr 30, 2024 | Sequencing Systems |
Jona announced a new distribution partnership where practitioners can order Jona kits, the company’s AI-powered gut microbiome profile test.
Read MorePosted by Andy Lundin | Apr 29, 2024 | Compliance |
The U.S. FDA finalized a rule regarding its oversight of LDTs to make explicit that IVDs are considered devices under the FD&C Act.
Read MorePosted by Andy Lundin | Apr 29, 2024 | Disease States |
The FDA approved Labcorp’s companion diagnostic test designed to determine eligibility for Pfizer’s gene therapy for hemophilia B patients.
Read More